ERAP1′s enzymatic activity can impact the risk of these diseases: when increased, the risk for ankylosing spondylitis and psoriasis is elevated, whereas when it is reduced, the risk decreases for Birdshot chorioretinopathy (BSCR) and Behçet’s disease. This evidence concerns the gene ERAP1 and Behcet disease.